Related Experiment Video
Updated: Aug 6, 2026

08:20
Superior Auto-Identification of Trypanosome Parasites by Using a Hybrid Deep-Learning Model
Published on: October 27, 2023
Artificial Intelligence in Infectious Disease Research
Kanniganti Bharathi1, Jeetendra Yadav2,3, Siddhant Shastri1
1ICMR-National Institute for Research in Digital Health (ICMR-NIRDH), New Delhi, India.
Ecohealth
|August 5, 2026
Summary
Artificial intelligence (AI) is advancing infectious disease diagnostics, with high-income countries leading research. Global collaboration is crucial to address disparities and implement AI effectively in infectious disease research.
Area of Science:
- Medical Informatics
- Computational Biology
- Public Health
Background:
- Infectious diseases pose a significant global health threat.
- Artificial intelligence (AI) shows promise in enhancing diagnostic techniques like CT, PET, MRI, and ultrasound.
- The full potential of AI in infectious disease detection and management requires further exploration.
Purpose of the Study:
- To examine global research trends in AI-driven diagnostics for infectious diseases.
- To identify key contributors and thematic shifts in this research area.
- To analyze the geographical distribution and collaboration patterns.
Main Methods:
- Bibliometric analysis of 5465 publications from 2005-2024 from the Web of Science database.
- Keywords included "infectious disease," "communicable disease," "environment," "machine learning," and "artificial intelligence."
- Analysis using pyBibX, bibliometrix, and VOSviewer for trend, author, institution, journal, and thematic mapping.
Main Results:
- The USA leads in publications and citations, followed by China and India.
- Top institutions include the Chinese Academy of Science, University of Oxford, and Harvard Medical School.
- Six key research themes were identified, with machine learning central to diagnostics, epidemiology, imaging, and drug discovery.
- Regional disparities were noted, with underrepresentation from low-income countries.
Conclusions:
- AI is transforming infectious disease research, primarily driven by high-income nations.
- Emerging collaborations in lower-middle-income countries signal a need for equitable AI adoption.
- Global partnerships are essential to overcome disparities in infrastructure, funding, and computational capabilities for AI implementation.
